Brooke Story - Jun 14, 2021 Form 4 Insider Report for Sigilon Therapeutics, Inc. (SGTX)

Role
Director
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
Stock symbol
SGTX
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
4
Date filed
6/16/2021, 04:10 PM
Next filing
May 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGTX Stock Option (Right to Buy) Award $0 +17.8K $0.00 17.8K Jun 14, 2021 Common Stock 17.8K $11.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vest as to one-third of the shares on each of June 14, 2022, June 14, 2023 and June 14, 2024.